Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 3Breast Neoplasms 3Neoplasm Metastasis 2Bone Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Melanoma 1Kidney Neoplasms 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Abdominal Pain 1

Interventions

Gemcitabine 170130-nm albumin-bound paclitaxel 54Albumin-Bound Paclitaxel 42Oxaliplatin 33Fluorouracil 32pembrolizumab 30Capecitabine 30Leucovorin 28Irinotecan 28Radiotherapy 25Nivolumab 22Erlotinib Hydrochloride 21Taxes 19Cisplatin 19Bevacizumab 15Magnetic Resonance Spectroscopy 13Specimen Handling 12Radiosurgery 11Ipilimumab 11Cyclophosphamide 11Drug Therapy 10Carboplatin 10Biopsy 10Paclitaxel 9Docetaxel 9Cetuximab 9trametinib 8olaparib 8durvalumab 8Sorafenib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pancreatic Neoplasms × Cryosurgery × Clear all
NCT01335945 2021-07-16

Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer

Boston Scientific Corporation

Phase 1 Terminated
14 enrolled
Gastrointestinal

Pain, Pancreatic Neoplasms, Abdominal Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡